Recent BCEL News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/11/2024 08:12:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:10:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:00:49 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 01/05/2024 09:57:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/26/2023 01:39:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 01:38:16 PM
- Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome • GlobeNewswire Inc. • 12/26/2023 01:30:00 PM
- Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives • GlobeNewswire Inc. • 11/14/2023 09:30:08 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 11:20:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 12:01:01 PM
- Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross • GlobeNewswire Inc. • 09/21/2023 12:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 08:01:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/18/2023 04:15:19 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/16/2023 09:20:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:06:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:42 PM
- Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring • GlobeNewswire Inc. • 08/10/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/04/2023 10:54:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/04/2023 10:53:40 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/19/2023 01:18:50 PM
- Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting • GlobeNewswire Inc. • 06/05/2023 12:00:29 PM
- Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments • GlobeNewswire Inc. • 05/10/2023 08:05:25 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM